Header cover image

Polish (WIG) Biotech Industry Analysis

UpdatedSep 26, 2023
DataAggregated Company Financials
Companies15
  • 7D-4.1%
  • 3M-0.7%
  • 1Y3.0%
  • YTD-3.2%

Over the last 7 days, the Biotech industry has dropped 4.1%, driven by Bioceltix declining 20%. In the past year, the industry has gained 3.0%. In the next few years, earnings are forecast to decline by 12% annually.

Industry Valuation and Performance

Has the Polish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 26 Sep 2023zł2.7bzł518.5m-zł61,744,678.0049.4x-44.5x5.3x
Thu, 24 Aug 2023zł2.8bzł520.3m-zł43,292,668.0050.1x-64.8x5.4x
Sat, 22 Jul 2023zł2.9bzł520.7m-zł42,515,291.0054.3x-68.4x5.6x
Mon, 19 Jun 2023zł2.8bzł517.3m-zł42,548,721.0062.6x-66.8x5.5x
Wed, 17 May 2023zł2.9bzł520.8m-zł42,603,826.0066.5x-68.3x5.6x
Fri, 14 Apr 2023zł2.8bzł492.8m-zł18,098,449.0062.1x-156.3x5.7x
Sun, 12 Mar 2023zł2.8bzł488.6m-zł16,165,349.0064.2x-173.9x5.8x
Tue, 07 Feb 2023zł3.0bzł496.5m-zł10,783,764.0047.1x-274.2x6x
Thu, 05 Jan 2023zł2.9bzł496.5m-zł10,783,764.0048.7x-266.2x5.8x
Sat, 03 Dec 2022zł2.7bzł457.9m-zł19,209,766.0045x-141.9x6x
Mon, 31 Oct 2022zł2.7bzł444.0m-zł13,473,868.0058.2x-197.2x6x
Wed, 28 Sep 2022zł2.6bzł390.2m-zł18,886,868.0057.4x-136.3x6.6x
Fri, 26 Aug 2022zł2.9bzł390.2m-zł7,043,258.0062.3x-405.3x7.3x
Sun, 24 Jul 2022zł2.5bzł472.9mzł66,686.0027.1x37861.6x5.3x
Tue, 21 Jun 2022zł2.3bzł472.3mzł5.7m24.9x403.7x4.9x
Thu, 19 May 2022zł2.6bzł424.4mzł11.6m41.5x224.5x6.2x
Sat, 16 Apr 2022zł2.7bzł366.7m-zł37,207,677.0033.2x-73.6x7.5x
Mon, 14 Mar 2022zł2.7bzł348.8m-zł40,884,677.0028.4x-65.3x7.7x
Wed, 09 Feb 2022zł3.2bzł369.9m-zł24,922,742.0051.2x-128.2x8.6x
Fri, 07 Jan 2022zł3.7bzł369.9m-zł24,922,742.0049.2x-147.6x9.9x
Sun, 05 Dec 2021zł3.7bzł369.9m-zł24,922,742.0048.9x-149.4x10.1x
Tue, 02 Nov 2021zł3.9bzł364.5m-zł1,455,285.0032.9x-2665.5x10.6x
Thu, 30 Sep 2021zł3.7bzł364.5m-zł1,455,285.0034.8x-2510.5x10x
Sat, 28 Aug 2021zł3.6bzł362.9m-zł8,912,285.0039.6x-404.9x9.9x
Sun, 04 Jul 2021zł3.8bzł362.9m-zł8,912,285.0040.5x-430.2x10.6x
Wed, 07 Apr 2021zł3.6bzł373.1m-zł6,705,220.00119.9x-533.9x9.6x
Sat, 09 Jan 2021zł1.5bzł382.5mzł56.4m87.8x27x4x
Fri, 02 Oct 2020zł1.9bzł307.0m-zł7,012,804.0039.5x-269.8x6.2x
Price to Earnings Ratio

-269.8x


Total Market Cap: zł1.9bTotal Earnings: -zł7,012,804.00Total Revenue: zł307.0mTotal Market Cap vs Earnings and Revenue0%0%0%
Polish Biotech Industry Price to Earnings3Y Average 1458.8x202120222023
Current Industry PE
  • Investors are pessimistic on the Polish Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 7.0x is higher than the industry's current PS ratio of 5.3x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 19% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Polish Biotech compare with similar industries?

PL Market-1.09%
Healthcare-2.33%
Biotech-4.10%
Biotech-4.10%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BIO BIOTONzł3.901.7%
+zł5.6m
10.8%PE76.4x
PUR Pure Biologicszł13.960.3%
+zł128.6k
-55.4%PS142x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SVE

zł5.21

Synthaverse

7D

-1.4%

1Y

-16.0%

MAB

zł17.01

Mabion

7D

-3.1%

1Y

-19.8%

PTG

zł59.40

Poltreg

7D

-1.3%

1Y

85.6%

CTX

zł121.00

Captor Therapeutics Spolka Akcyjna

7D

-1.6%

1Y

-15.7%

PUR

zł13.96

Pure Biologics

7D

0.3%

1Y

-55.4%

BIO

zł3.90

BIOTON

7D

1.7%

1Y

10.8%

GX1

zł6.94

genXone

7D

-9.9%

1Y

-49.0%

URT

zł106.00

Urteste

7D

-3.6%

1Y

35.9%

GMT

zł10.00

Genomtec

7D

-15.3%

1Y

83.5%